Corporate News tagged:
Product Catalog
Jan 10, 2025
PRESS RELEASE: Qkine announces partnership with REPROCELL: Global distributorship for high quality bioactive proteins for stem cell culture
Qkine Ltd., and REPROCELL Inc., have partnered to globally distribute high-quality proteins such as growth factors and cytokines manufactured by Qkine.
Feb 13, 2020
Prof Stefan Przyborski to give Keynote Address at this year’s SMi 3D Cell Culture Conference
Read the announcement that REPROCELL Europe’s Prof Stefan Przyborski will giving the keynote address on 3D cell culture at the SMi Annual Conference London
Nov 04, 2019
Appointment of New Distributor in Thailand
Read about the REPROCELL groups distributorship agreement with A.N.H. Scientific Marketing Co. Ltd. to distribute REPROCELL’s products and services in Thailand
Aug 22, 2019
PRESS RELEASE: ABLE Biott Bioreactors now available in Europe
REPROCELL announce the launch of ABLE Biott Bioreactors in Europe. The lab-scale system will allow researchers to culture stem cells in suspension.
May 20, 2016
REPROCELL Europe’s (formerly Reinnervate’s) CSO Prof Stefan Przyborski to give an Alvetex Seminar at the University of Oxford, 24 May 2016
Professor Stefan Przyborski, Chief Scientific Officer of REPROCELL Europe (formerly Reinnervate), is to give a seminar on Alvetex next week, 24th May 2016.
Mar 22, 2016
Reinnervate Ltd wins Corporate Vision’s 2015 Technology Innovator Award for Alvetex
We are pleased to announce that Reinnervate Ltd has been awarded Corporate Vision’s 2015 Technology Innovator Award for Alvetex 3D cell culture. Alvetex has been awarded the title, “Most Advanced 3D Cell Technology.”
Jan 14, 2016
Alvetex in Space
While the first British ESA astronaut Tim Peake is currently on the International Space Station (ISS) and is about to make his first spacewalk, now is a good time to mention again that Reinnervate’s flagship product, Alvetex® Scaffold, has been used as part of a BBSRC-funded project on the ISS in recent months.
Jun 30, 2015
Stemgent, a REPROCELL Group Company Announces a New High Performance Self-replicative RNA Reprogramming Kit
Read REPROCELL Group company Stemgent inc.'s announcement of a New High Performance Self-replicative RNA Reprogramming Kit: Stemgent StemRNA™-SR
Apr 20, 2015
Alvetex® 3D cell culture platform reaches new heights with project aboard the International Space Station (ISS).
Market leading 3D cell culture company Reinnervate Ltd, part of the ReproCELL group, today announced that a rocket carrying its Alvetex® Scaffold technology blasted into Space this week. Alvetex will be used in experiments on board the International Space Station (ISS).
Mar 05, 2015
New paper demonstrates formation of spontaneously active neuronal networks by stem cell derived neurons in 3D Alvetex Scaffold culture system
A recently published paper by Imogen Smith et al. demonstrates the use of the Alvetex platform to culture 3D differentiated human neural stem cells.
Oct 08, 2014
Alvetex Scaffold 384 well plates used in an Oncology HTS program by AstraZeneca
Read more about how scientists at AstraZeneca in the UK are using Alvetex Scaffold in an automated Oncology HTS (High Throughput Screening) setting.
Sep 09, 2014
REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business
Aug 05, 2014
Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)
Read about the Japanese regenerative medicine company REPROCELL Inc. and its acquisition of Reinnervate Ltd. (UK), and BioServe Inc. of MD, USA.
Feb 05, 2014
Launch of Reinnervate Perfusion System for 3D cell culture
Read about Reinnervates announcement of the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media.
Nov 04, 2013
Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture
3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO’s to offer 3D tumour cell screening services.
Sep 19, 2013
Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies
Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services using Alvetex® technology.
Aug 22, 2013
Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013
Read the announcement that Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course.
Jul 31, 2013
Alvetex 3D cell culture scaffolds chosen by investigators at Massachusetts General Hospital for study of bone loss during space flight
Alvetex Scaffold system has been chosen by a group at Massachusetts General Hospital for the first ever 3D osteocytic cell culture experiments in microgravity
Jan 07, 2013
3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement
Learn more about how Oncotest is integrating Alvetex Scaffold 3d cell culture technology into its cancer research screening services.
Dec 14, 2012
3D cell culture firm Reinnervate announces the release of Alvetex®Scaffold 96 well plates for high throughput 3D cell-based assays
Market leading 3D cell culture company, Reinnervate Ltd, today announced that it has launched and commenced shipments of Alvetex® Scaffold 96 well plates to customers.